03.05.2022
Towards an EU strategy to promote education for children in the world: mitigating the impact of the COVID-19 pandemic
Referenz: A9-0058/2022
03.05.2022
The persecution of minorities on the grounds of belief or religion
Referenz: A9-0071/2022
03.05.2022
The EU Action plan on Organic Agriculture
Referenz: A9-0126/2022
03.05.2022
Toward a sustainable blue economy in the EU: the role of the fisheries and aquaculture sectors
Referenz: A9-0089/2022
03.05.2022 Cyprus
Schengen Information System (SIS): application of the provisions of the Schengen acquis in Cyprus
Referenz: A9-0082/2022
03.05.2022
Common system of value added tax (VAT): extension of the application period of the optional reverse charge mechanism in relation to supplies of certain goods and services susceptible to fraud and of the Quick Reaction Mechanism against VAT fraud
Referenz: A9-0128/2022
03.05.2022
Persistent organic pollutants
Referenz: A9-0092/2022
03.05.2022
Proposal for a Council Regulation on the election of the members of the European Parliament by direct universal suffrage, repealing Council Decision (76/787/ECSC, EEC, Euratom) and the Act concerning the election of the members of the European Parliament by direct universal suffrage annexed to that decision
Referenz: A9-0083/2022
07.04.2022
Parliament’s estimates of revenue and expenditure for the financial year 2023
Referenz: A9-0087/2022
07.04.2022
Right to repair
Referenz: B9-0175/2022
07.04.2022
The Schengen evaluation mechanism
Referenz: A9-0054/2022
07.04.2022
Conclusions of the European Council meeting of 24-25 March 2022: including the latest developments of the war against Ukraine and the EU sanctions against Russia and their implementation
Referenz: RC-B9-0197/2022
07.04.2022
EU Protection of children and young people fleeing the war against Ukraine
Referenz: B9-0207/2022
07.04.2022
Gas storage
Referenz: C9-0126/2022
07.04.2022
Increased pre-financing from REACT-EU
Referenz: C9-0132/2021
07.04.2022 Ireland Malta United Kingdom Cyprus
Investigational medicinal products made available in the UK with respect to Northern Ireland, Cyprus, Ireland and Malta
Referenz: C9-0476/2021
07.04.2022 Ireland Malta United Kingdom Cyprus
Medicinal products made available in the UK with respect to Northern Ireland, Cyprus, Ireland and Malta
Referenz: C9-0475/2021
06.04.2022
Objection pursuant to Rule 112(2) and (3): Genetically modified soybean MON 87769 X MON 89788
Referenz: B9-0178/2022